CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C12604 | BRD-K32071534 | BRD-K32071534 | -- | -- | -- | Details |
C12605 | BRD-K32078195 | BRD-K32078195 | -- | -- | -- | Details |
C12606 | BRD-K32079609 | BRD-K32079609 | -- | -- | -- | Details |
C12607 | BRD-K32082369 | BRD-K32082369 | -- | -- | -- | Details |
C12608 | BRD-K32083350 | BRD-K32083350 | -- | -- | -- | Details |
C12609 | BRD-K32084247 | BRD-K32084247 | -- | -- | -- | Details |
C12610 | BRD-K32088574 | BRD-K32088574 | -- | -- | -- | Details |
C12611 | BRD-K32093012 | BRD-K32093012 | -- | -- | -- | Details |
C12612 | BRD-K32099399 | BRD-K32099399 | -- | -- | -- | Details |
C12613 | BRD-K32100931 | BRD-K32100931 | -- | -- | -- | Details |
C12614 | BRD-K32101625 | LX-1031 | -- | -- | -- | Details |
C12615 | BRD-K32101742 | BRD-K32101742 | -- | -- | -- | Details |
C12616 | BRD-K32106123 | BRD-K32106123 | -- | -- | -- | Details |
C12617 | BRD-K32107296 | temozolomide | MGMT | DNA alkylating agent | -- | Details |
C12618 | BRD-K32111336 | BRD-K32111336 | -- | -- | -- | Details |
C12619 | BRD-K32112425 | BRD-K32112425 | -- | -- | -- | Details |
C12620 | BRD-K32118188 | BRD-K32118188 | -- | -- | -- | Details |
C12621 | BRD-K32120119 | BRD-K32120119 | -- | -- | -- | Details |
C12622 | BRD-K32124229 | BRD-K32124229 | -- | -- | -- | Details |
C12623 | BRD-K32127177 | BRD-K32127177 | -- | -- | -- | Details |
C12624 | BRD-K32128027 | BRD-K32128027 | -- | -- | -- | Details |
C12625 | BRD-K32131036 | BRD-K32131036 | -- | -- | -- | Details |
C12626 | BRD-K32132269 | BRD-K32132269 | -- | -- | -- | Details |
C12627 | BRD-K32132728 | BRD-K32132728 | -- | -- | -- | Details |
C12628 | BRD-K32137326 | BRD-K32137326 | -- | -- | -- | Details |
C12629 | BRD-K32138919 | SA-90471 | -- | -- | -- | Details |
C12630 | BRD-K32145037 | BRD-K32145037 | -- | -- | -- | Details |
C12631 | BRD-K32146668 | BRD-K32146668 | -- | -- | -- | Details |
C12632 | BRD-K32159948 | BRD-K32159948 | -- | -- | -- | Details |
C12633 | BRD-K32162364 | BRD-K32162364 | -- | -- | -- | Details |
C12634 | BRD-K32162437 | BRD-K32162437 | -- | -- | -- | Details |
C12635 | BRD-K32162676 | BRD-K32162676 | -- | -- | -- | Details |
C12636 | BRD-K32163723 | BRD-K32163723 | -- | -- | -- | Details |
C12637 | BRD-K32164935 | tolazamide | -- | -- | -- | Details |
C12638 | BRD-K32170456 | BRD-K32170456 | -- | -- | -- | Details |
C12639 | BRD-K32173944 | BRD-K32173944 | -- | -- | -- | Details |
C12640 | BRD-K32176914 | BRD-K32176914 | -- | -- | -- | Details |
C12641 | BRD-K32183200 | BRD-K32183200 | -- | -- | -- | Details |
C12642 | BRD-K32185509 | BRD-K32185509 | -- | -- | -- | Details |
C12643 | BRD-K32185628 | BRD-K32185628 | -- | -- | -- | Details |
C12644 | BRD-K32186766 | BRD-K32186766 | -- | -- | -- | Details |
C12645 | BRD-K32188552 | BRD-K32188552 | -- | -- | -- | Details |
C12646 | BRD-K32191695 | BRD-K32191695 | -- | -- | -- | Details |
C12647 | BRD-K32195266 | BRD-K32195266 | -- | -- | -- | Details |
C12648 | BRD-K32197572 | BRD-K32197572 | -- | -- | -- | Details |
C12649 | BRD-K32199799 | BRD-K32199799 | -- | -- | -- | Details |
C12650 | BRD-K32205799 | BRD-K32205799 | -- | -- | -- | Details |
C12651 | BRD-K32208085 | BRD-K32208085 | -- | -- | -- | Details |
C12652 | BRD-K32209551 | BRD-K32209551 | -- | -- | -- | Details |
C12653 | BRD-K32214429 | BRD-K32214429 | -- | -- | -- | Details |
C12654 | BRD-K32218650 | MBX-2982 | GPR119 | Glucose dependent insulinotropic receptor agonist | -- | Details |
C12655 | BRD-K32223081 | BRD-K32223081 | -- | -- | -- | Details |
C12656 | BRD-K32231531 | BRD-K32231531 | -- | -- | -- | Details |
C12657 | BRD-K32231853 | BRD-K32231853 | -- | -- | -- | Details |
C12658 | BRD-K32233845 | BRD-K32233845 | -- | -- | -- | Details |
C12659 | BRD-K32234234 | BRD-K32234234 | -- | -- | -- | Details |
C12660 | BRD-K32235162 | BRD-K32235162 | -- | -- | -- | Details |
C12661 | BRD-K32238524 | BRD-K32238524 | -- | -- | -- | Details |
C12662 | BRD-K32240435 | BRD-K32240435 | -- | -- | -- | Details |
C12663 | BRD-K32240700 | BRD-K32240700 | -- | -- | -- | Details |
C12664 | BRD-K32247306 | primidone | GABRA1; GABRA2; GABRA3; GABRA4; GABRA5; GABRA6; GABRB1; GABRB2; GABRB3; GABRD; GABRE; GABRG1; GABRG2; GABRG3; GABRP; GABRQ | GABA receptor antagonist | -- | Details |
C12665 | BRD-K32251128 | BRD-K32251128 | -- | -- | -- | Details |
C12666 | BRD-K32253397 | BRD-K32253397 | -- | -- | -- | Details |
C12667 | BRD-K32256916 | cinnarizine | HRH1 | Calcium channel blocker | -- | Details |
C12668 | BRD-K32259584 | BRD-K32259584 | -- | -- | -- | Details |
C12669 | BRD-K32269272 | BRD-K32269272 | -- | -- | -- | Details |
C12670 | BRD-K32271530 | BRD-K32271530 | -- | -- | -- | Details |
C12671 | BRD-K32272500 | BRD-K32272500 | -- | -- | -- | Details |
C12672 | BRD-K32273377 | sulfadiazine | -- | -- | -- | Details |
C12673 | BRD-K32277249 | BRD-K32277249 | -- | -- | -- | Details |
C12674 | BRD-K32280984 | BRD-K32280984 | -- | -- | -- | Details |
C12675 | BRD-K32282076 | BRD-K32282076 | -- | -- | -- | Details |
C12676 | BRD-K32285926 | AMG-208 | MET | Tyrosine kinase inhibitor | -- | Details |
C12677 | BRD-K32290015 | BRD-K32290015 | -- | -- | -- | Details |
C12678 | BRD-K32292990 | CGP-53353 | EGFR | PKC inhibitor; EGFR inhibitor | -- | Details |
C12679 | BRD-K32294814 | BRD-K32294814 | -- | -- | -- | Details |
C12680 | BRD-K32297746 | BRD-K32297746 | -- | -- | -- | Details |
C12681 | BRD-K32301393 | BRD-K32301393 | -- | -- | -- | Details |
C12682 | BRD-K32307229 | BRD-K32307229 | -- | -- | -- | Details |
C12683 | BRD-K32310489 | BRD-K32310489 | -- | -- | -- | Details |
C12684 | BRD-K32311154 | nifekalant | -- | -- | -- | Details |
C12685 | BRD-K32318651 | acyclovir | -- | -- | -- | Details |
C12686 | BRD-K32319151 | BRD-K32319151 | -- | -- | -- | Details |
C12687 | BRD-K32320888 | BRD-K32320888 | -- | -- | -- | Details |
C12688 | BRD-K32321439 | BRD-K32321439 | -- | -- | -- | Details |
C12689 | BRD-K32323656 | BRD-K32323656 | -- | -- | -- | Details |
C12690 | BRD-K32324469 | BRD-K32324469 | -- | -- | -- | Details |
C12691 | BRD-K32326107 | BRD-K32326107 | -- | -- | -- | Details |
C12692 | BRD-K32330804 | BRD-K32330804 | -- | -- | -- | Details |
C12693 | BRD-K32330832 | VER-155008 | HSPA1A | HSP inhibitor | -- | Details |
C12694 | BRD-K32343246 | BRD-K32343246 | -- | -- | -- | Details |
C12695 | BRD-K32345392 | BRD-K32345392 | -- | -- | -- | Details |
C12696 | BRD-K32349359 | ML-89-9 | -- | -- | -- | Details |
C12697 | BRD-K32350897 | BRD-K32350897 | -- | -- | -- | Details |
C12698 | BRD-K32354807 | BRD-K32354807 | -- | -- | -- | Details |
C12699 | BRD-K32362211 | BRD-K32362211 | -- | -- | -- | Details |
C12700 | BRD-K32367664 | BRD-K32367664 | -- | -- | -- | Details |
C12701 | BRD-K32370845 | BRD-K32370845 | -- | -- | -- | Details |
C12702 | BRD-K32373560 | BRD-K32373560 | -- | -- | -- | Details |
C12703 | BRD-K32380790 | BRD-K32380790 | -- | -- | -- | Details |